Resultados da busca - Edelgard Lindhoff‐Last
- Mostrando 1 - 12 resultados de 12
-
1
-
2
-
3
-
4
-
5
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin por Edelgard Lindhoff‐Last, Roumen Nakov, Frank Misselwitz, Hans‐Klaus Breddin, Rupert Bauersachs
Publicado em 2002Artigo -
6
-
7
Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia por Dirk Walter, Hans Krankenberg, Jörn O. Balzer, Christoph Kalka, Iris Baumgärtner, Michael Schlüter, Torsten Tonn, Florian Seeger, Stefanie Dimmeler, Edelgard Lindhoff‐Last, Andreas M. Zeiher
Publicado em 2011Artigo -
8
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants por Robert C. Gosselin, Dorothy M. Adcock, Shannon M. Bates, Jonathan Douxfils, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen
Publicado em 2018Artigo -
9
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants por Jonathan Douxfils, Dorothy M. Adcock, Shannon M. Bates, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen, Robert C. Gosselin
Publicado em 2021Revisão -
10
Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis por Linda Schönborn, Sabrina E. Seck, Thomas Thiele, Lars Kaderali, Till Hoffmann, A Hlinka, Edelgard Lindhoff‐Last, Uwe Völker, Kathleen Selleng, Alessandra Buoninfante, Marco Cavaleri, Andreas Greinacher
Publicado em 2023Artigo -
11
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia por Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf, Sebastian Schellong, Pascal M. Dohmen, Johannes Brachmann, Katharina Madlener, Bernd Pötzsch, Robert Klamroth, Johannes Hankowitz, Norbert Banik, Sonja Eberle, Markus Müller, Stefan Kropff, Edelgard Lindhoff‐Last
Publicado em 2017Artigo -
12
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure por Linda Schönborn, Olga Esteban, Jan Wesche, Paulina Dobosz, Marta Broto, Sara Rovira Puig, Jessica Fuhrmann, Raquel Torres, Josep Serra, Roser Llevadot, Marta Palicio, Jing Jing Wang, Tom P. Gordon, Edelgard Lindhoff‐Last, Till Hoffmann, Lorenzo Alberio, Florian Länger, Christian Boehme, Eugenia Biguzzi, Leonie Grosse, Matthias Endres, Thomas Liman, Thomas Thiele, Theodore E. Warkentin, Andreas Greinacher
Publicado em 2023Artigo
Ferramentas de busca:
Assuntos relacionados
Internal medicine
Medicine
Heparin
Platelet
Surgery
Anesthesia
Apixaban
Atrial fibrillation
Dabigatran
Rivaroxaban
Thrombosis
Warfarin
Coagulation
Immunology
Intensive care medicine
Antibody
Coagulation testing
Computer science
Edoxaban
Gastroenterology
Heparin-induced thrombocytopenia
Incidence (geometry)
Lepirudin
Medical physics
Operating system
Optics
Pathology
Pharmacology
Physics
Platelet factor 4